Company

Hemera Pharma

Biotechnology Research Verona, IT 13 employees GNTA

Employees: 13
Contacts: 3
Emails: 3

hemerapharma.com LinkedIn

Hemera Pharma Overview

Headquarters: Verona, IT
Website: hemerapharma.com
Industry: Biotechnology Research
Employees: 13
Founded: 2021
Stock Symbol: GNTA
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Regenerative Medicine Cell Therapy Orphan Disease Orphan Drug Advanced Therapy Central Nervous System Disorders Regeneration of Damaged Nervous Tissue Spinal Cord Injury Acute Neurological Trauma

About Hemera Pharma

Spin-off of the University of Verona and the University of Milan specialized in regenerative medicine for neurological diseases. After years of studies and research conducted by its founding scientists, Hemera is born to develop a revolutionary cellular therapy for the regeneration of damaged nerve tissues, which finds its first application in the treatment of acute spinal cord injuries.

Hemera Pharma Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Hemera Pharma Org Chart

Sample employees and titles

Name	Title	Location	Contact
Cristiana Vignoli	Chief Executive Officer at Hemera - Ambassador Gammadonna - #fab50 2023 - Women Startup Award 2023 - Angel Investor		View
Michela Pantaleoni	Pharma, Biotech & Medtech Advisor - 20+ Yrs in Pricing & Market Access - Rare Diseases, Oncology & Early Asset Evaluation - Strategic Launch & Access	Milan, Lombardy, Italy	Email
Luca Andrea Baroldi Torelli	Board Member X Te! Digital Healthcare Services. Shareholder and Scientific Director Easy Health, Digital Medecine Solutions. Shareholder & Mentor	Milan, Lombardy, Italy	Email
Alessandra Marconi	Strategic Project & Operations Manager - Budgeting & Grant Coordination - Simplify, Organize, and Make Things Happen	Greater Bergamo Metropolitan Area, Italy	Email